fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

CBD Treatment Case: Fighting Cancer

Published

on

Cancer has been referred to as the plague of the 20th century. However, given the course of progress we have seen over the past 18 years, it may well be on its way to being the plague of the 21st century as well.

Cancer impacts everything in the animal kingdom. But be glad that you’re a mammal (we are assuming that everyone reading this is most likely a mammal). Mammals are the only class of animals equipped with an endocannabinoid system. And, as we will show below, the endocannabinoid system can be an important ally in the fight against cancer.

Cancer and the Endocannabinoid System

Research often takes an interesting path. Scientists understand the important questions based on feedback that emerges in a more qualitative way through one’s experiences in the world. And often times, the main inspiration for an important target for new research comes from anecdotal evidence – stories people tell of the experiences they’ve had.

How often have you seen this happen? Someone has an extraordinary experience that highlights a possible conceptual relationship, and then someone else realizes that, through controlled experimentation, we can figure out whether or not there really is something there.

That’s when science takes over.

This is exactly what has happened where our understanding of the relationship between the endocannabinoid system and cancer is concerned. A tremendous amount of anecdotal evidence has emerged that has been sufficient enough to point scientists and researchers toward the importance of studying it on a more scientific basis.

This process has led to an important discovery: from what we have found, basically every form of cancer seems to exhibit an extraordinarily high density of CB2 receptors. And, because CB2 receptors are in charge of regulating many important things, including how chemicals involved in the functionality of the immune system are rapidly produced in cells, we are able now to understand that these receptors are critical to a process known as apoptosis.

Apoptosis is also known as pre-programmed cell death. This is the process of a cell passing from what we might think of as “natural causes”. It is the end of the normal life cycle for a cell in your body.

This is always going on. In fact, this happens to you about 80 billion times every day. If it stopped happening, you would have quite a problem. Imagine if you had an extra 80 billion cells added to you every day. Poignantly, you would have, in effect, the worst case of cancer ever. Because that’s just what cancer is.

Cancer cells don’t die in the normal manner at the normal age. They just keep proliferating.

CBD and the Fight against Cancer

Because cancer cells have a higher density of the CB2 receptors, the antigen blocking factor of endocannabinoids causes cancer cells to live between 10-20 times as long as normal cells.

However, as we have noted, phytocannabinoids are very different from endocannabinoids. CBD is an excellent example.

CBD is a “negative allosteric modulator”. That sounds like a big fancy ten-dollar phrase, and it is. But what it means is pretty simple: CBD essentially is able to block the normal way that endocannabinoids bind with CB2 receptors. This makes those receptors less responsive to activators such as endocannabinoids or THC, but more responsive to deactivators like CBG.

Hence, while research is still in its early stages, we may find increasing evidence over time that could confirm the idea that CBD may have anticancer effects through aiding in the partial reintroduction of some level of healthy apoptosis to cancer cells.

CBD CONDITIONS & TREATMENTS

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) Signs An Accord To Become A Supplier Of Vaporizable Products To Pax Era In Canada

Published

on

Supreme Cannabis Company Inc (OTCMKTS:SPRWF) has entered a pact to supply vaporizable products in Canada. Supreme Cannabis joined hands with Pax Labs to enter the vaporizer market in Canada with their proven brands.

7Acres to supply cannabis oil pods

Pax has selected 7Acres, a wholly owned subsidiary of Supreme Cannabis, to supply cannabis oil pods for Pax Era. The company already sold more than 1.5 million devices across the world. It is one of the reputed firms to supply pen and pod systems in the US. The proven brand development ability of Supreme Cannabis along with high quality cannabis flower provides a unique opportunity in the market. The alliance with Pax will improve the growth of vaporizer products.

Chief Executive Officer of Supreme Cannabis, Navdeep Dhaliwal said the company is pleased to partner with Pax to offer excellent vaporizing experience to the customers. 7Acres will supply oils extracted from cannabis flower for Pax Era, the premium vaporizer, in North America.

Navdeep further said 7Acres has established itself as a leader in the supply of premium quality cannabis flower on a large scale in Canada. The company is now expanding the Canada brand into innovative product categories.  It will maintain the same quality to the valued customers. The company is excited to work PAX to offer premium brand experience to the customers on Pax Era platform.

Sells vaporizer oil in Era-compatible pods

As per the terms of the accord, the company will sell vaporizer oil under the 7Acres brand in Era compatible pods. Supreme Cannabis will also supply pods under different brands for Pax Era. 7Acres expects to sell Pax Era pods under the 7Acres brand in areas where Supreme Cannabis holds provincial supply accords.

Welcomes Health Canada final regulations

Supreme Cannabis has welcomed final regulations released by Health Canada. Under the newly released regulations, licensed holders are allowed production and sale of cannabis extracts, edibles, and topicals. Supreme Cannabis would develop good quality cannabis extracts that comprise oils, concentrates, vaping liquids, and tinctures under its own brands. The alliance with Pax allows Supreme Cannabis to enter the cannabis category.

Supreme Cannabis also plans to supply oils and extracts under its pact with Khalifa Kush Enterprises Canada ULC. The company’s proposed takeover of Blissco Cannabis Corp allows engaging in new product development.

Continue Reading

CBD CONDITIONS & TREATMENTS

Cresco Labs Inc (OTCMKTS:CRLBF) Inaugurates VidaCann Dispensaries In Jacksonville And Pensacola And Expands Retail Footprint In Florida

Published

on

Cresco Labs Inc (OTCMKTS:CRLBF) has inaugurated new Vidacann medical cannabis dispensaries in Jacksonville and Pensacola cities in Florida. Co-founder and Chief Executive Officer of Cresco, Charlie Bachtell said since the takeover announced in March 2019, Vidacann has expanded its retail footprint in the state. The company will close the acquisition of Vidacann within 90 days.

12 dispensaries in Florida

With the opening of two new medical cannabis dispensaries, Vidacann now has 12 dispensaries in Florida. The most advanced and one of the biggest medical cannabis providers in Florida, Vidacann will improve the retail presence in the two biggest cities: Jacksonville and Pensacola by opening new dispensaries. Cresco will have the fifth biggest retail dispensaries network in Florida.

Cresco expects a weekly patient growth of 10,000 in Florida with the opening of new dispensaries in Pensacola and Jacksonville. It plans to increase the count of dispensaries in the state to 20 by 2029.

Cresco sets a revenue target of $1 billion

Cresco has become one of the multi-state operators in just 30 days with a couple of takeovers recently. The company announced accord to takeover Origin House in April 2019. As per the terms of the deal, the shareholders of Origin House will get 0.8428 shares of Cresco for each of their share in Origin House. The deal is valued at $1.1 billion CAD. It makes the biggest public company takeover in cannabis space in the US for Cresco.

Cresco has set a revenue target of $1 billion by the year 2021. Its Q3 2019 revenues are reported at $12 million. The company aims to become one of the biggest cannabis players in the world.

Cresco owns licenses in 51 retail locations and have access to 11 states following the takeover of Vidacann. The takeover of Origin House provides Cresco access to California distribution network of 50 brand relationships and 500 dispensary partners. Revenues from California market is expected at $7.7 billion by the year 2022.

Cresco will have access to New York, Michigan and Florida. These states together with California would offer a better opportunity for the company. With all these developments in place, the valuation of the stock are estimated at $4.1 billion.

Continue Reading

CBD CONDITIONS & TREATMENTS

Future Farm Technologies Inc (OTCMKTS:FFRMF) Completes Indoor Cultivation Stage And Expects To Produce 130,000 Pounds Of Biomass From 2019 Crop

Published

on

Future Farm Technologies Inc (OTCMKTS:FFRMF) has completed 2019 hemp for wellness crop’s indoor cultivation stage. The company is ready to transplant 200,000 seedlings in Hersey, Maine based 100 acre facility.

Expects yield of 130,000 pounds

Future Farm expects an output of 130,000 pounds of biomass from 2019 hemp crop. The company will transplant the seedlings at right time in the climate controlled indoor facility. Perfect timing of the seedlings will help to grow healthy plants and get higher yield of cannabidiol and other valuable bi-products.

Zero THC products

Future Farm will seek the help of processing providers to process biomass produced from the crop. The company will supply extracts, isolates, high quality distillates, zero THC products, and water-soluble products to the product manufacturers.

The Managers (Growing Operation) of Future Farm, Nate Gray and Zachary Lapan said they are confident of achieving a bumper 2019 crop with the application of experience gained in the inaugural 2018 harvest and processing.

Issues an update on Florida operations

Future Farm said its operations in Apopka, Florida based White Sand Nursery are in full swing. It started the 3 truckloads of spring accent plants shipments per week in March 2019 to one of the biggest customers in White Sand. The company expected to ship 850,000 3.5” plants in the first week of June 2019. Expected revenues from these shipments are estimated at $500,000. Future Farm is planning to fulfill the pre-booked orders of 845,000 plants from clients across the nation in fall season.

Chief Executive Officer of Future Farm, William Gildea said he is pleased with the accomplishments achieved by the management at White Sands. He is thrilled to ship truckloads of good quality products in a healthy condition.

Enters pact with Northeast Processing

Future Farm has signed an accord with Vermont based Northeast Processing for the processing, testing and packaging of its hemp cultivated in a Maine based 100 acre facility in 2019.

Northeast converts the Future Farm produced hemp biomass into CBD isolate, whole plant extract, and CBD distillate in just 4 months. Future Farm is searching for customers to supply its isolate, distillate and full spectrum extracts for wellness and health products.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories